Jazz Share Price
NASDAQ: JAZZ | Large Cap | HealthcareJazz Stock Performance
Jazz Share Price Today
As of 21 November 2026, Jazz Pharmaceuticals plc (Ireland)'s share price is $230.57. The stock opened at $235.78, compared to its previous close of $236.34. During today's trading session, Jazz Pharmaceuticals plc (Ireland)'s share price traded between $227.96 and $238.11, with an average price of $233.03. Over the past 52 weeks, the stock has recorded a high of $266.28 and a low of $157.01. In terms of performance, Jazz Pharmaceuticals plc (Ireland)'s share price has declined by 2.58% over the last six months and is up 30.50% on a year-on-year basis.
Jazz Share Price Chart
Jazz Quarterly Profit & Loss
All figures in USD
Jazz Annual Profit & Loss
All figures in USD
Jazz Balance Sheet
All figures in USD Billion
Jazz Cash Flow
All figures in USD Million
About Jazz
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Jazz Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $216.62 | $230.20 | +6.57% |
Oct 2026 | $230.99 | $216.00 | -6.78% |
Sep 2026 | $252.50 | $231.72 | -7.66% |
Aug 2026 | $253.13 | $250.94 | -0.63% |
Jul 2026 | $239.57 | $252.54 | +4.80% |
Jun 2026 | $235.50 | $240.98 | +1.82% |
May 2026 | $203.54 | $236.68 | +16.59% |
Apr 2026 | $190.13 | $203.01 | +7.53% |
Mar 2026 | $187.93 | $188.79 | -0.61% |
Feb 2026 | $165.48 | $189.94 | +15.45% |
Jan 2026 | $170.01 | $164.52 | -3.23% |
Dec 2025 | $174.76 | $170.01 | -3.78% |
